Senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID 19 vaccine to administer to a volunteer, at a clinic in London, Wednesday, Aug. 5, 2020. Scientists at Imperial College London are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. (AP Photo/Kirsty Wigglesworth)

Canada signs deals with two suppliers for potential COVID-19 vaccines

This is the third such deal Canada has made with COVID-19 vaccine developers

Prime Minister Justin Trudeau says the federal government has signed agreements with two more American suppliers to reserve millions of doses of their experimental COVID-19 vaccines for Canadians.

Deals are now in place for Canada to get access to vaccines being tested by both Johnson & Johnson and Novavax. Earlier this month Ottawa signed similar deals with Pfizer and Moderna.

“Their most recent vaccine tests show promising results,” said Trudeau. “That’s why we’re making sure that if one of these potential vaccines is successful, Canada and Canadians will have access to the doses they need.”

The vaccines are still in either Phase 2 or 3 clinical trials and won’t be purchased unless they are deemed safe and effective by Health Canada.

Trudeau says all told Canada could get access to at least 88 million doses of vaccines. Some vaccines will require more than one dose to be effective.

The agreement with Novavax, a Maryland-based biotech company, is for up to 76 million doses of its vaccine, which is in Phase 2 clinical trials in the United States and Australia right now. That means it’s being tested for safety and efficacy in a fairly small number of people. The earliest date that vaccine might be ready for widespread use is next spring.

The agreement with Johnson & Johnson is for up to 38 million doses. A Phase 1 and 2 trial of that vaccine is underway in the U.S. and Belgium.

The government says some of the doses of whatever vaccine is approved may be produced at a new biomanufacturing facility at the Human Health Therapeutics Research Centre in Montreal. The new facility is intended to produce up to two million doses of vaccine a month by the end of next summer.

Mia Rabson, The Canadian Press

READ MORE: 30% of British Columbians would ‘wait and see’ before taking COVID vaccine: poll

READ MORE: Misinformation online plays role in COVID-19 vaccine hesitancy: Tam


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

CanadaCoronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Motor home burns up at north Nanaimo intersection

No one hurt in incident Friday morning at old Island Highway, Rutherford Road and Mostar Road

70-year-old punched in the head in dispute over disability parking space in Nanaimo

Senior’s turban knocked off in incident at parking lot at Lowe’s last month

LETTER TO THE EDITOR: It’s Island’s turn for investment in light rail

Convert rail right-of-way to a double-tracked light rail system, says letter writer

RDN signs deal with Nanaimo Recycling Exchange to conduct waste audits

RDN working on mandatory waste-separation bylaw for industrial, commercial, institutional sectors

Nanaimo RCMP community policing needs a few good volunteers

Volunteers needed to help Nanaimo RCMP and city deliver crime prevention and safety programs

VIDEO: B.C. to launch mouth-rinse COVID-19 test for kids

Test involves swishing and gargling saline in mouth and no deep-nasal swab

Beefs & Bouquets, Sept. 16

To submit a beef or a bouquet to the Nanaimo News Bulletin, e-mail bulletinboard@nanaimobulletin.com

Record-breaking 165 new COVID-19 cases diagnosed in B.C. in 24-hour period

Fifty-seven people are in hospital battling the novel coronavirus

B.C. teachers file Labour Relations Board application over COVID-19 classroom concerns

The application comes as B.C.’s second week of the new school year comes to a close

Young Canadians have curtailed vaping during pandemic, survey finds

The survey funded by Heart & Stroke also found the decrease in vaping frequency is most notable in British Columbia and Ontario

Long-term care need pressuring acute care in Comox Valley, Strathcona

Region could use a couple of large facilities for seniors on the north part of the Island

B.C.’s COVID-19 economic recovery plan: Top 5 things you need to know

Jobs training, tax incentives for employers to hire staff and more

B.C. releases details of $1.5B economic recovery plan, $660M in business tax incentives

Economic plan includes support for employers, as well as training for workers

Most Read